Beta Drugs Limited IPO (BETA)
Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently asked questions
What is the price band for the Beta Drugs Limited IPO?
The Beta Drugs Limited IPO price band is 85 per share.
When does the Beta Drugs Limited IPO open and close?
Bidding opens 29 September 2017 and closes 4 October 2017.
Is the Beta Drugs Limited IPO a mainboard or SME issue?
Beta Drugs Limited is an SME IPO, listing on NSE Emerge.
When did the Beta Drugs Limited IPO list?
Beta Drugs Limited listed on 12 October 2017.
Does this page show the grey market premium (GMP) for Beta Drugs Limited?
No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.
Is investing in the Beta Drugs Limited IPO recommended by BrokerLens?
No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.